TickerFacts.

Treace Medical Concepts, Inc. (TMCI): Cost of Revenue

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2021-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$42.94M
Year ended 2025-12-31
$42.19M
Trailing 12 months to 2026-06-30
+18.9%
3-year compound annual growth
2019-12-31: $7.63M2020-12-31: $12.47M2021-12-31: $16.89M2022-12-31: $25.53M2023-12-31: $35.18M2024-12-31: $41.09M2025-12-31: $42.94M$42.94M
2019-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$42.94M+4.5%2026-02-27, From 2025-01-01
2024-12-31$41.09M+16.8%2026-02-27, From 2024-01-01
2023-12-31$35.18M+37.8%2026-02-27, From 2023-01-01
2022-12-31$25.53M+51.2%2025-02-27, From 2022-01-01
2021-12-31$16.89Mn/c2024-02-27, From 2021-01-01
2020-12-31$12.47M+63.4%2023-03-08, From 2020-01-01
2019-12-31$7.63Mn/a2022-03-04, From 2019-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Treace Medical Concepts, Inc. (TMCI)2025-12-31$42.94M+4.5%
SI-BONE, Inc. (SIBN)2025-12-31$41.05M+17.1%
Orthopediatrics Corp (KIDS)2025-12-31$63.69M+13.5%
Lemaitre Vascular Inc (LMAT)2025-12-31$71.06M+3.0%
Heartflow, Inc. (HTFL)2025-12-31$40.84M+30.2%
SkinHealth Systems Inc. (SKIN)2025-12-31$104.43M-31.3%
Neuronetics, Inc. (STIM)2025-12-31$76.85M+270.7%
PROCEPT BioRobotics Corp (PRCT)2025-12-31$111.83M+28.0%
InfuSystem Holdings, Inc (INFU)2025-12-31$63.14M-2.0%

Compare TMCI, SIBN, KIDS, LMAT side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗